Department of Nuclear Medicine, National PET/Cyclotron Center, Taipei Veterans General Hospital, Taipei, Taiwan.
J Nucl Med. 2010 Jun;51(6):883-91. doi: 10.2967/jnumed.109.070565. Epub 2010 May 19.
This study aimed to define the potential of 1-(11)C-acetate PET, compared with (18)F-FDG, in detecting meningiomas and monitoring the effect of gamma-knife radiosurgery.
Twenty-two patients with the neuroradiologic diagnosis of meningioma were examined by 1-(11)C-acetate and (18)F-FDG PET on the same day. There were 12 cases of histopathologically proven meningioma (8 grade I, 2 grade II, and 2 grade III), 1 of tuberculous granuloma, and 1 of degenerative tissue. 1-(11)C-acetate PET scans of fasting patients were obtained 10 min after intravenous administration of 740 MBq of 1-(11)C-acetate. (18)F-FDG PET was performed at 2 h after 1-(11)C-acetate scanning. The PET images were evaluated by a qualitative method and semiquantitative analysis using standardized uptake value and tumor-to-cortex ratio.
The (18)F-FDG PET study revealed a hypometabolic focus in 17 meningiomas (8 grade I, 1 grade II, and 8 unknown grade) and hypermetabolism in 1 grade II and 2 grade III meningiomas. High uptake of 1-(11)C-acetate was observed in all 20 meningiomas, in contrast to the low uptake in surrounding normal brain tissue, allowing a clearer demarcation of the tumor boundary than that provided by (18)F-FDG. Dissociation of regional accumulation of 1-(11)C-acetate and (18)F-FDG within the tumor was also noted on the coregistered images. The standardized uptake value for 1-(11)C-acetate was not different from that for (18)F-FDG (mean +/- SD, 3.16 +/- 1.75 vs. 3.22 +/- 1.50, P = 0.601), but the tumor-to-cortex ratio for 1-(11)C-acetate was higher than that for (18)F-FDG (3.46 +/- 1.38 vs. 0.93 +/- 1.08, P < 0.005). (18)F-FDG was able to differentiate grade I from grade II-III meningiomas, whereas 1-(11)C-acetate was unable to do so. Tuberculous granuloma had a high 1-(11)C-acetate and (18)F-FDG uptake similar to that of grade II/III meningioma. Five patients received 1-(11)C-acetate and (18)F-FDG PET before and after gamma-knife surgery. 1-(11)C-acetate performed better than did (18)F-FDG in monitoring the response of tumor metabolism to radiosurgery.
1-(11)C-acetate was found to be useful for detecting meningiomas and evaluating the extent of meningiomas and potentially useful for monitoring tumor response to radiosurgery. However, 1-(11)C-acetate was not useful for evaluating the tumor grade. (18)F-FDG was found to be less useful than 1-(11)C-acetate for evaluating the extent of meningiomas and the response to radiosurgical treatment but may be useful for differentiating benign from malignant meningiomas. (18)F-FDG and 1-(11)C-acetate are complementary for assessing diverse cell metabolism of meningioma.
本研究旨在比较 1-(11)C-乙酸盐 PET 与 (18)F-FDG 对脑膜瘤的检测潜力,并监测伽玛刀放射外科治疗的效果。
22 例经神经影像学诊断为脑膜瘤的患者在同一天接受 1-(11)C-乙酸盐和 (18)F-FDG PET 检查。其中 12 例为经组织病理学证实的脑膜瘤(8 级 I、2 级 II 和 2 级 III)、1 例为结核性肉芽肿、1 例为退行性组织。禁食患者在静脉注射 740MBq 1-(11)C-乙酸盐后 10 分钟进行 1-(11)C-乙酸盐 PET 扫描。在 1-(11)C-乙酸盐扫描后 2 小时进行 (18)F-FDG PET。使用标准化摄取值和肿瘤与皮质比值进行定性方法和半定量分析评估 PET 图像。
(18)F-FDG PET 研究显示 17 例脑膜瘤(8 级 I、1 级 II 和 8 例未知分级)代谢活跃,1 例 2 级 II 脑膜瘤和 2 例 3 级脑膜瘤代谢活跃。20 例脑膜瘤均可见 1-(11)C-乙酸盐高摄取,与周围正常脑组织摄取低形成鲜明对比,肿瘤边界比 (18)F-FDG 更清晰。在配准图像上还观察到肿瘤内 1-(11)C-乙酸盐和 (18)F-FDG 区域积聚的分离。1-(11)C-乙酸盐的标准化摄取值与 (18)F-FDG 无差异(均值 +/- SD,3.16 +/- 1.75 比 3.22 +/- 1.50,P = 0.601),但 1-(11)C-乙酸盐的肿瘤与皮质比值高于 (18)F-FDG(3.46 +/- 1.38 比 0.93 +/- 1.08,P < 0.005)。(18)F-FDG 能够区分 1 级和 2-3 级脑膜瘤,而 1-(11)C-乙酸盐则不能。结核性肉芽肿具有与 2/3 级脑膜瘤相似的高 1-(11)C-乙酸盐和 (18)F-FDG 摄取。5 例患者在伽玛刀手术前后接受 1-(11)C-乙酸盐和 (18)F-FDG PET 检查。1-(11)C-乙酸盐在监测肿瘤代谢对放射外科治疗的反应方面优于 (18)F-FDG。
发现 1-(11)C-乙酸盐对检测脑膜瘤、评估脑膜瘤范围以及潜在监测肿瘤对放射外科治疗的反应均有用。然而,1-(11)C-乙酸盐在评估肿瘤分级方面没有用处。(18)F-FDG 对评估脑膜瘤范围和放射治疗反应的效果不如 1-(11)C-乙酸盐,但可能有助于区分良性和恶性脑膜瘤。(18)F-FDG 和 1-(11)C-乙酸盐可互补评估脑膜瘤的不同细胞代谢。